Nasdaq turns positive on biotech boost
Source: | Filed in
Health & Drug | 
Subscribe to Savvy Investor via RSS
9/21/09NEW YORK (Reuters) – The Nasdaq turned positive on Monday as shares of biotechnology companies advanced, but the drag from retreating commodity prices kept both the Dow and the S&P 500 in negative territory.
* The rise in biotechnology companies followed a brokerage’s raised recommendation on Celgene Corp (NasdaqGS:CELG – News), up almost 5 percent at $55.02.
* A weaker-than-expected reading in a forward-looking measure of the U.S. economy also curbed the broader market.
* The Dow Jones industrial average (DJI:^DJI – News) was down 35.22 points, or 0.36 percent, at 9,784.98. The Standard & Poor’s 500 Index (^SPX – News) was down 3.72 points, or 0.35 percent, at 1,064.58. The Nasdaq Composite Index (Nasdaq:^IXIC – News) was up 4.12 points, or 0.19 percent, at 2,137.00.
